We are proud to share that MSInsight has been selected for the Innov’Up Leader France 2030 Ile de France program, a innovation grant led by Région Île-de-France and French Gouvernment through Plan France 2030.
This support will help us strengthen our R&D efforts and advance our mission: delivering reliable microsatellite instability (MSI) analysis to empower precision oncology.
Innovation in healthcare isn’t built on buzzwords — it’s built on rigorous science, reproducibility, and time-tested clinical principles. Innov’Up backs projects that respect that approach, and we are honored to be among those selected.
Thank you to our partners, collaborators, and advisors who have supported us in bringing trusted diagnostic innovation to the clinic. And thank you to Région Île-de-France and Bpifrance for investing in meaningful, evidence-based medical technology.
Diagnose Better. Treat Smarter.
